Innoviva, Inc.
US ˙ NasdaqGS ˙ US45781M1018

SecurityINVA / Innoviva, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership588,529 shares
Latest Disclosed Value $ 11,764,695
Barclays Plc ownership in INVA / Innoviva, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 588,529 shares of Innoviva, Inc. (US:INVA) valued at $11,764,695 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 334,777 shares of Innoviva, Inc.. This represents a change in shares of 75.80% during the quarter. The current value of the position is $12,771,079 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (INVA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

INVA / Innoviva, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F INNOVIVA COM 45781M101 588,529 253,752 75.80 11,765 92.57 0.0028
2026-03-31 2025-09-30 13F/A-3 INNOVIVA COM 45781M101 334,777 196,096 141.40 6,110 119.27 0.0013
2026-03-19 2025-09-30 13F/A-2 INNOVIVA COM 45781M101 100,594 -38,087 1,942 0.0005
2025-11-12 2025-09-30 13F INNOVIVA COM 45781M101 334,777 196,096 6,110 0.0013
2026-02-27 2025-06-30 13F/A-2 INNOVIVA COM 45781M101 138,681 55,333 66.39 2,786 84.38 0.0006
2025-08-14 2025-06-30 13F/A-1 INNOVIVA COM 45781M101 138,681 55,333 3 0.0006
2025-08-13 2025-06-30 13F INNOVIVA COM 45781M101 138,681 55,333 3 0.0002
2026-03-17 2025-03-31 13F/A-1 INNOVIVA COM 45781M101 83,348 -27,131 -24.56 1,511 -21.14 0.0004
2025-05-15 2025-03-31 13F INNOVIVA COM 45781M101 83,348 -27,131 2 0.0004
2026-03-19 2024-12-31 13F/A-1 INNOVIVA COM 45781M101 110,479 9,885 9.83 1,917 -1.34 0.0005
2025-02-13 2024-12-31 13F INNOVIVA COM 45781M101 110,479 9,885 2 0.0005
2026-03-31 2024-09-30 13F/A-2 INNOVIVA COM 45781M101 100,594 72,192 254.18 1,942 317.63 0.0005
2024-11-19 2024-09-30 13F/A-1 INNOVIVA COM 45781M101 100,594 72,192 2 0.0005
2024-11-15 2024-09-30 13F INNOVIVA COM 45781M101 100,594 72,192 2 0.0005
2026-03-23 2024-06-30 13F/A-1 INNOVIVA COM 45781M101 28,402 -31,360 -52.47 466 -48.90 0.0001
2024-08-14 2024-06-30 13F INNOVIVA COM 45781M101 28,402 -31,360 0 0.0001
2026-03-24 2024-03-31 13F/A-1 INNOVIVA COM 45781M101 59,762 27,665 86.19 911 605.43 0.0003
2024-05-15 2024-03-31 13F INNOVIVA COM 45781M101 59,762 27,665 1 0.0003
2026-03-25 2023-12-31 13F/A-1 THESEUS PHARMACEUTICALS COM 88369M101 32,097 24,265 309.82 130 514.29 0.0000
2026-03-25 2023-12-31 13F/A-1 INNOVIVA COM 45781M101 104,668 96,836 1,679 0.0002
2024-02-15 2023-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 32,097 24,265 0 0.0000
2024-02-15 2023-12-31 13F INNOVIVA COM 45781M101 104,668 63,711 2 0.0002
2026-03-26 2023-09-30 13F/A-1 THESEUS PHARMACEUTICALS COM 88369M101 7,832 -533 -6.37 21 -73.08 0.0000
2026-03-26 2023-09-30 13F/A-1 INNOVIVA COM 45781M101 40,957 32,592 532 0.0001
2023-11-07 2023-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 7,832 -533 0 0.0000
2023-11-07 2023-09-30 13F INNOVIVA COM 45781M101 40,957 5,995 1 0.0003
2026-03-30 2023-06-30 13F/A-2 THESEUS PHARMACEUTICALS COM 88369M101 8,365 -4,628 -35.62 78 -32.17 0.0000
2026-03-30 2023-06-30 13F/A-2 INNOVIVA COM 45781M101 34,962 34,962 445 0.0001
2023-09-20 2023-06-30 13F/A-1 THESEUS PHARMACEUTICALS COM 88369M101 8,365 -4,628 0 0.0000
2023-09-20 2023-06-30 13F/A-1 INNOVIVA COM 45781M101 34,962 -25,802 0 0.0003
2023-08-03 2023-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 8,365 -4,628 0 0.0000
2023-08-03 2023-06-30 13F INNOVIVA COM 45781M101 34,962 -25,802 0 0.0003
2026-03-30 2023-03-31 13F/A-1 THESEUS PHARMACEUTICALS COM 88369M101 12,993 4,089 45.92 115 161.36 0.0001
2026-03-30 2023-03-31 13F/A-1 INNOVIVA COM 45781M101 60,764 753 684 0.0001
2023-05-04 2023-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 12,993 4,089 0 0.0001
2023-05-04 2023-03-31 13F INNOVIVA COM 45781M101 60,764 753 1 0.0003
2026-03-30 2022-12-31 13F/A-1 THESEUS PHARMACEUTICALS COM 88369M101 8,904 3,844 75.97 44 51.72 0.0000
2026-03-30 2022-12-31 13F/A-1 INNOVIVA COM 45781M101 60,011 54,951 795 0.0001
2023-02-13 2022-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 8,904 3,844 0 0.0000
2023-02-13 2022-12-31 13F INNOVIVA COM 45781M101 60,011 -7,053 1 0.0004
2022-11-03 2022-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 5,060 -132 -2.54 29 0.00 0.0000
2022-11-03 2022-09-30 13F INNOVIVA COM 45781M101 67,064 -25,003 779 0.0009
2022-08-12 2022-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 5,192 -1,018 -16.39 29 -59.72 0.0000
2022-08-12 2022-06-30 13F INNOVIVA COM 45781M101 92,067 14,592 1,359 0.0008
2022-05-16 2022-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 6,210 -79,603 -92.76 72 -95.14 0.0001
2022-05-16 2022-03-31 13F INNOVIVA COM 45781M101 77,475 -8,338 1,500 0.0012
2022-02-23 2021-12-31 13F/A-1 INNOVIVA COM 45781M101 85,813 13,446 18.58 1,481 22.30 0.0006
2022-02-14 2021-12-31 13F INNOVIVA COM 45781M101 85,813 13,446 1,481 0.0002
2021-11-09 2021-09-30 13F INNOVIVA COM 45781M101 72,367 18,923 35.41 1,211 68.90 0.0005
2021-08-13 2021-06-30 13F INNOVIVA COM 45781M101 53,444 -47,782 -47.20 717 -40.69 0.0003
2021-05-13 2021-03-31 13F INNOVIVA COM 45781M101 101,226 -21,632 -17.61 1,209 -20.57 0.0006
2021-02-11 2020-12-31 13F INNOVIVA COM 45781M101 122,858 -2,206 -1.76 1,522 16.54 0.0008
2020-11-12 2020-09-30 13F INNOVIVA COM 45781M101 125,064 18,379 17.23 1,306 -12.41 0.0008
2020-08-12 2020-06-30 13F INNOVIVA COM 45781M101 106,685 41,558 63.81 1,491 94.39 0.0012
2020-05-13 2020-03-31 13F INNOVIVA COM 45781M101 65,127 -34,406 -34.57 767 -45.53 0.0006
2020-02-10 2019-12-31 13F INNOVIVA COM 45781M101 99,533 -82,953 -45.46 1,408 -26.82 0.0008
2019-11-15 2019-09-30 13F/A-1 INNOVIVA COM 45781M101 182,486 70,561 63.04 1,924 18.11 0.0012
2019-11-14 2019-09-30 13F INNOVIVA COM 45781M101 182,486 70,561 1,924 444.8310
2019-08-14 2019-06-30 13F INNOVIVA COM 45781M101 111,925 6,680 6.35 1,629 10.29 0.0010
2019-05-15 2019-03-31 13F INNOVIVA COM 45781M101 105,245 34,283 48.31 1,477 19.21 0.0010
2019-02-14 2018-12-31 13F INNOVIVA COM 45781M101 70,962 -22,905 -24.40 1,239 -13.42 0.0010
2018-11-14 2018-09-30 13F INNOVIVA COM 45781M101 93,867 28,141 42.82 1,431 57.77 0.0010
2018-08-14 2018-06-30 13F INNOVIVA COM 45781M101 65,726 36,013 121.20 907 82.86 0.0008
2018-05-15 2018-03-31 13F INNOVIVA COM 45781M101 29,713 12,359 71.22 496 101.63 0.0004
2018-02-14 2017-12-31 13F INNOVIVA COM 45781M101 17,354 -16,541 -48.80 246 -48.64 0.0002
2017-11-14 2017-09-30 13F INNOVIVA COM 45781M101 33,895 14,550 75.21 479 93.15 0.0005
2017-08-14 2017-06-30 13F INNOVIVA COM 45781M101 19,345 -32,396 -62.61 248 -65.31 0.0003
2017-05-15 2017-03-31 13F INNOVIVA COM 45781M101 51,741 41,373 399.05 715 544.14 0.0008
2017-02-14 2016-12-31 13F INNOVIVA COM 45781M101 10,368 5,516 113.69 111 105.56 0.0001
2016-11-14 2016-09-30 13F INNOVIVA COM 45781M101 4,852 -17,428 -78.22 54 -77.02 0.0001
2016-08-12 2016-06-30 13F INNOVIVA COM 45781M101 22,280 18,414 476.31 235 410.87 0.0003
2016-05-16 2016-03-31 13F INNOVIVA COM 45781M101 3,866 -505 -11.55 46 4.55 0.0001
2016-02-12 2015-12-31 13F THERAVANCE COM 88338T104 4,371 -29,348 -87.04 44 -81.36 0.0001
2015-11-13 2015-09-30 13F THERAVANCE COM 88338T104 33,719 27,871 476.59 236 124.76 0.0003
2015-08-14 2015-06-30 13F THERAVANCE COM 88338T104 5,848 -53,801 -90.20 105 -88.26 0.0001
2015-05-19 2015-03-31 13F/A-1 THERAVANCE COM 88338T104 59,649 46,054 338.76 894 370.53 0.0010
2015-05-14 2015-03-31 13F THERAVANCE COM 88338T104 59,649 894
2015-02-13 2014-12-31 13F THERAVANCE COM 88338T104 13,595 -3,622 -21.04 190 -35.15 0.0002
2014-11-14 2014-09-30 13F THERAVANCE COM 88338T104 17,217 -12,729 -42.51 293 -66.24 0.0003
2014-08-14 2014-06-30 13F THERAVANCE COM 88338T104 29,946 -27,317 -47.70 868 -49.51 0.0009
2014-05-15 2014-03-31 13F THERAVANCE COM 88338T104 57,263 50,988 812.56 1,719 681.36 0.0019
2014-02-13 2013-12-31 13F THERAVANCE COM 88338T104 6,275 -6,760 -51.86 220 -57.77 0.0002
2013-11-14 2013-09-30 13F THERAVANCE COM 88338T104 13,035 -39,834 -75.34 521 -74.42 0.0006
2013-08-14 2013-06-30 13F THERAVANCE COM 88338T104 52,869 52,869 2,037 0.0025
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-05-15 2019-03-31 13F INNOVIVA OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-14 2018-12-31 13F INNOVIVA OPT Call 100 -75.00 2 -66.67 n/a n/a n/a
2018-11-14 2018-09-30 13F INNOVIVA OPT Call 400 300.00 6 500.00 n/a n/a n/a
2018-08-14 2018-06-30 13F INNOVIVA OPT Call 100 0.00 1 -50.00 n/a n/a n/a
2018-05-15 2018-03-31 13F INNOVIVA OPT Call 100 0.00 2 100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F INNOVIVA OPT Call 100 -66.67 1 -75.00 n/a n/a n/a
2017-11-14 2017-09-30 13F INNOVIVA OPT Call 300 -25.00 4 -20.00 n/a n/a n/a
2017-08-14 2017-06-30 13F INNOVIVA OPT Call 400 -50.00 5 -54.55 n/a n/a n/a
2017-05-15 2017-03-31 13F INNOVIVA OPT Call 800 -55.56 11 -42.11 n/a n/a n/a
2017-02-14 2016-12-31 13F INNOVIVA OPT Call 1,800 5.88 19 0.00 n/a n/a n/a
2016-11-14 2016-09-30 13F INNOVIVA OPT Call 1,700 -37.04 19 -32.14 n/a n/a n/a
2016-08-12 2016-06-30 13F INNOVIVA OPT Call 2,700 -92.33 28 -93.36 n/a n/a n/a
2016-05-16 2016-03-31 13F INNOVIVA OPT Call 35,200 5,766.67 422 6,933.33 n/a n/a n/a
2016-02-12 2015-12-31 13F THERAVANCE OPT Call 600 -86.96 6 -81.25 n/a n/a n/a
2015-11-13 2015-09-30 13F THERAVANCE OPT Call 4,600 0.00 32 -61.45 n/a n/a n/a
2015-08-14 2015-06-30 13F THERAVANCE OPT Call 4,600 360.00 83 453.33 n/a n/a n/a
2015-05-19 2015-03-31 13F/A THERAVANCE OPT Call 1,000 -80.77 15 -79.45 n/a n/a n/a
2015-05-14 2015-03-31 13F THERAVANCE OPT Call 1,000 15 n/a n/a n/a
2015-02-13 2014-12-31 13F THERAVANCE OPT Call 5,200 -70.29 73 -75.42 n/a n/a n/a
2014-11-14 2014-09-30 13F THERAVANCE OPT Call 17,500 84.21 297 7.61 n/a n/a n/a
2014-08-14 2014-06-30 13F THERAVANCE OPT Call 9,500 -44.77 276 -46.51 n/a n/a n/a
2014-05-15 2014-03-31 13F THERAVANCE OPT Call 17,200 17.01 516 0.19 n/a n/a n/a
2014-02-13 2013-12-31 13F THERAVANCE OPT Call 14,700 -77.42 515 -80.22 n/a n/a n/a
2013-11-14 2013-09-30 13F THERAVANCE OPT Call 65,100 -12.85 2,604 -9.52 n/a n/a n/a
2013-08-14 2013-06-30 13F THERAVANCE OPT Call 74,700 2,878 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-05-15 2019-03-31 13F INNOVIVA OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-14 2018-12-31 13F INNOVIVA OPT Put 300 -66.67 5 -64.29 n/a n/a n/a
2018-11-14 2018-09-30 13F INNOVIVA OPT Put 900 -18.18 14 -6.67 n/a n/a n/a
2018-08-14 2018-06-30 13F INNOVIVA OPT Put 1,100 57.14 15 25.00 n/a n/a n/a
2018-05-15 2018-03-31 13F INNOVIVA OPT Put 700 600.00 12 1,100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F INNOVIVA OPT Put 100 0.00 1 0.00 n/a n/a n/a
2017-11-14 2017-09-30 13F INNOVIVA OPT Put 100 -94.74 1 -96.15 n/a n/a n/a
2017-05-15 2017-03-31 13F INNOVIVA OPT Put 1,900 -79.35 26 -73.47 n/a n/a n/a
2017-02-14 2016-12-31 13F INNOVIVA OPT Put 9,200 0.00 98 -2.97 n/a n/a n/a
2016-11-14 2016-09-30 13F INNOVIVA OPT Put 9,200 -76.47 101 -75.49 n/a n/a n/a
2016-08-12 2016-06-30 13F INNOVIVA OPT Put 39,100 412 n/a n/a n/a
2016-05-16 2016-03-31 13F THERAVANCE OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-12 2015-12-31 13F THERAVANCE OPT Put 100 -83.33 1 -75.00 n/a n/a n/a
2015-11-13 2015-09-30 13F THERAVANCE OPT Put 600 -83.33 4 -93.85 n/a n/a n/a
2015-08-14 2015-06-30 13F THERAVANCE OPT Put 3,600 -99.80 65 -99.76 n/a n/a n/a
2015-05-19 2015-03-31 13F/A THERAVANCE OPT Put 1,838,100 21,273.26 27,572 22,876.67 n/a n/a n/a
2015-05-14 2015-03-31 13F THERAVANCE OPT Put 1,838,100 27,572 n/a n/a n/a
2015-02-13 2014-12-31 13F THERAVANCE OPT Put 8,600 36.51 120 12.15 n/a n/a n/a
2014-11-14 2014-09-30 13F THERAVANCE OPT Put 6,300 -5.97 107 -45.13 n/a n/a n/a
2014-08-14 2014-06-30 13F THERAVANCE OPT Put 6,700 -92.12 195 -92.35 n/a n/a n/a
2014-05-15 2014-03-31 13F THERAVANCE OPT Put 85,000 385.71 2,550 315.99 n/a n/a n/a
2014-02-13 2013-12-31 13F THERAVANCE OPT Put 17,500 -34.46 613 -42.60 n/a n/a n/a
2013-11-14 2013-09-30 13F THERAVANCE OPT Put 26,700 8.98 1,068 13.14 n/a n/a n/a
2013-08-14 2013-06-30 13F THERAVANCE OPT Put 24,500 944 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.